
### [NCIT:C36083](http://purl.obolibrary.org/obo/NCIT_C36083)
**Label:** Intraductal Breast Neoplasm

**Subclasses:** [NCIT:C7645](http://purl.obolibrary.org/obo/NCIT_C7645) (Intracystic Papillary Breast Carcinoma), [NCIT:C5137](http://purl.obolibrary.org/obo/NCIT_C5137) (Intraductal Non-Comedo Breast Adenocarcinoma), [NCIT:C5138](http://purl.obolibrary.org/obo/NCIT_C5138) (Intraductal Cribriform Breast Adenocarcinoma), [NCIT:C3863](http://purl.obolibrary.org/obo/NCIT_C3863) (Intraductal Breast Papilloma), [NCIT:C36090](http://purl.obolibrary.org/obo/NCIT_C36090) (Intraductal Papillary Breast Neoplasm), [NCIT:C66933](http://purl.obolibrary.org/obo/NCIT_C66933) (Ductal Breast Carcinoma In Situ, Solid Type), [NCIT:C27944](http://purl.obolibrary.org/obo/NCIT_C27944) (Sclerosing Breast Papilloma), [NCIT:C27942](http://purl.obolibrary.org/obo/NCIT_C27942) (Intraductal Proliferative Lesion of the Breast), [NCIT:C4190](http://purl.obolibrary.org/obo/NCIT_C4190) (Intraductal Papillary Breast Carcinoma), [NCIT:C4191](http://purl.obolibrary.org/obo/NCIT_C4191) (Intracystic Papilloma), [NCIT:C36089](http://purl.obolibrary.org/obo/NCIT_C36089) (Atypical Breast Papilloma), [NCIT:C36088](http://purl.obolibrary.org/obo/NCIT_C36088) (Peripheral Breast Papilloma), [NCIT:C2924](http://purl.obolibrary.org/obo/NCIT_C2924) (Ductal Breast Carcinoma In Situ), 

**Class expressions from DL-Learner:**

- [NCIT:C36331](http://purl.obolibrary.org/obo/NCIT_C36331) (Polysomy) and (not ([NCIT:C37867](http://purl.obolibrary.org/obo/NCIT_C37867) (Tetrasomy 7))) 58.30%
- [NCIT:C36331](http://purl.obolibrary.org/obo/NCIT_C36331) (Polysomy) and (not ([NCIT:C36600](http://purl.obolibrary.org/obo/NCIT_C36600) (Tetrasomy 12))) 58.30%
- [NCIT:C36657](http://purl.obolibrary.org/obo/NCIT_C36657) (Polysomy 17) 55.00%
- [NCIT:C36656](http://purl.obolibrary.org/obo/NCIT_C36656) (Polysomy 10) 55.00%
- [NCIT:C36655](http://purl.obolibrary.org/obo/NCIT_C36655) (Polysomy 3) 55.00%
- [NCIT:C36331](http://purl.obolibrary.org/obo/NCIT_C36331) (Polysomy) 53.73%
- [NCIT:C36331](http://purl.obolibrary.org/obo/NCIT_C36331) (Polysomy) and (not ([NCIT:C38784](http://purl.obolibrary.org/obo/NCIT_C38784) (Apoptosis Pathway))) 53.73%
- [NCIT:C36331](http://purl.obolibrary.org/obo/NCIT_C36331) (Polysomy) and (not ([NCIT:C38770](http://purl.obolibrary.org/obo/NCIT_C38770) (Squamous Differentiation))) 53.73%
- [NCIT:C36331](http://purl.obolibrary.org/obo/NCIT_C36331) (Polysomy) and (not ([NCIT:C38762](http://purl.obolibrary.org/obo/NCIT_C38762) (Thyroid Gland Mucoepidermoid Carcinoma))) 53.73%
- [NCIT:C36331](http://purl.obolibrary.org/obo/NCIT_C36331) (Polysomy) and (not ([NCIT:C3876](http://purl.obolibrary.org/obo/NCIT_C3876) (Gastric Leiomyoma))) 53.73%
- [NCIT:C36331](http://purl.obolibrary.org/obo/NCIT_C36331) (Polysomy) and (not ([NCIT:C38759](http://purl.obolibrary.org/obo/NCIT_C38759) (EBV Infection))) 53.73%
- [NCIT:C36331](http://purl.obolibrary.org/obo/NCIT_C36331) (Polysomy) and (not ([NCIT:C38732](http://purl.obolibrary.org/obo/NCIT_C38732) (Defective Alpha Heavy Chain Present))) 53.73%
- [NCIT:C36331](http://purl.obolibrary.org/obo/NCIT_C36331) (Polysomy) and (not ([NCIT:C38731](http://purl.obolibrary.org/obo/NCIT_C38731) (Villous Atrophy))) 53.73%
- [NCIT:C36331](http://purl.obolibrary.org/obo/NCIT_C36331) (Polysomy) and (not ([NCIT:C38730](http://purl.obolibrary.org/obo/NCIT_C38730) (Lymphoepithelial Lesion))) 53.73%
- [NCIT:C36331](http://purl.obolibrary.org/obo/NCIT_C36331) (Polysomy) and (not ([NCIT:C38727](http://purl.obolibrary.org/obo/NCIT_C38727) (Villous Lymphocyte))) 53.73%


